Monkeypox 101

A NON-endemic spread of monkeypox has been reported in multiple countries – a phenomenon that has never happened before. The Centers for Disease Control and Prevention and the World Health Organization are developing plans for potential outbreaks – what are the 101s on this disease for healthcare providers? The GameChanger Most cases of monkeypox are self-limiting, but death rates up to 10% have been reported, particularly in children and immunosuppressed patients. Treatment options for monkeypox exist but have not been evaluated in large studies to prove efficacy or safety. Show Segments 00:00 – Introductions 01:24 – Monkeypox Background 08:29 – Monkeypox Presentation 09:32 – Combating & Treating Monkeypox 21:21 – Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and resources: CDC. Monkeypox and Smallpox Vaccine Guidance. WHO. Multi-country monkeypox outbreaks in non-endemic countries. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Redeem your CPE or CME credit CPE (Pharmacist) CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a Membership Prescribers: Get a Membership Continuing Education Information: Learning Objectives: 1. Describe the symptoms and signs of monkeypox 2. Discuss current status of vaccines against monkeypox in the US 0.05 CEU | 0.5 Hrs ACPE UAN: 0107-0000-22-276-H01-P Initial release date: 07/25/22 Expiration date: 07/25/2023 Additional CPE & CME details can be found here Follow CEimpact on Social Media: LinkedIn Instagram